Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

       
Total article views   HTML views PDF downloads Totals
12,042 Dovepress* 11,232+ 1,883 13,115
PubMed Central* 810 396 1,206
Totals 12,042 2,279 14,321
*Since 25 February 2015
+Since July 2016

View citations on PubMed and Google Scholar